Milestone Pharmaceuticals (MIST) PT Raised to $17 at Cowen Following Data
Tweet Send to a Friend
Cowen analyst Ritu Baral raised the price target on Milestone Pharmaceuticals (NASDAQ: MIST) to $17.00 (from $12.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
